Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-859

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 43598-859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Fosaprepitant For Injection 150 mg per vial label for lyophilized powder for intravenous use. The label directs reconstitution with 5 mL of 0.9% Sodium Chloride for Injection. It includes storage instructions, contraindications for use with certain divalent cations and solutions, and manufacturer information for Dr. Reddy's Laboratories Inc. The vial is single-dose with disposal instructions for unused portions.*

FDA Label Image

Label (Label)

Label for Fosaprepitant For Injection, 150 mg per vial, a single-dose vial for intravenous use. The label includes storage instructions to keep refrigerated, dosage information, and the labeler, Dr. Reddy's Laboratories Inc. It also features a barcode and states the product is made in India.*

FDA Label Image

Structure

Chemical structure of Fosaprepitant, showing the molecular arrangement including trifluoromethyl groups and other characteristic atoms as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.